In-vitro activity of coumermycin against methicillin-resistant staphylococci: a comparison with six other agents
- 1 August 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 18 (2) , 171-175
- https://doi.org/10.1093/jac/18.2.171
Abstract
The in-vitro activity of coumermycin was compared with that of vancomycin, rifampicin, fusidic acid, trimethoprim-sulphamethoxazole, norfloxacin and cefamandole against seven isolates of methicillin-resistant Staphylococcus aureus and 97 isolates of methicillin-resistant coagulase negative staphylococci. Apart from one strain of methicillin-resistant S. aureus all isolates were inhibited by ≤0.06 mg/l of coumermycin. Cefamandole was more active against strains of S. epidermidis than against other coagulase negative staphylococci.Keywords
This publication has 7 references indexed in Scilit:
- Species dependent variability in the susceptibility of coagulase-negative staphylococci to various antimicrobial agentsJournal of Antimicrobial Chemotherapy, 1985
- Use of trehalose-mannitol-phosphatase agar to differentiate Staphylococcus epidermidis and Staphylococcus saprophyticus from other coagulase-negative staphylococciJournal of Clinical Microbiology, 1984
- Antibacterial activity of coumermycin alone and in combination with other antibioticsAntimicrobial Agents and Chemotherapy, 1984
- Staphylococcus epidermidis InfectionsAnnals of Internal Medicine, 1983
- Characterization of coagulase-negative staphylococci from urinary tract specimensJournal of Clinical Microbiology, 1983
- Clinical significance of coagulase-negative staphylococciJournal of Clinical Microbiology, 1982
- Nosocomial Septicemia Due to Multiply Antibiotic-Resistant Staphylococcus epidermidisAnnals of Internal Medicine, 1982